Storia in 2 fonti

Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance

Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.

Raccontata da

cnbc.com

biopharmadive.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

cnbc.comStai leggendo3 mesi fa

Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance

Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.

originale

biopharmadive.com3 mesi fa

Novo hikes guidance on Wegovy pill’s fast sales start

In its latest earnings report, the Danish drugmaker said sales and profit should shrink less than the company originally anticipated thanks to strong prescription numbers for its new obesity pill.

Leggi questa versione → originale

Timeline cronologica

lunedì 4 maggio 2026·cnbc.com
Novo Nordisk’s Wegovy head start on pills forces investors to rethink Eli Lilly's GLP-1 dominance
Early signs from the launch of Novo Nordisk's Wegovy pill and Eli Lilly & Co.'s Foundayo are making investors rethink the opportunity for GLP-1 pills.
mercoledì 6 maggio 2026·cnbc.com
Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance
Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.

Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance

Novo hikes guidance on Wegovy pill’s fast sales start

Timeline cronologica

Novo Nordisk’s Wegovy head start on pills forces investors to rethink Eli Lilly's GLP-1 dominance

Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance

Novo hikes guidance on Wegovy pill’s fast sales start